This group comprises preparations used in the treatment of epilepsy.
Combined preparations are classified at separate 5th levels using the corresponding 50-series.
The group is subdivided according to chemical structure.

This group comprises antiepileptics, which cannot be classified in the preceding groups.
Fenfluramine indicated for the treatment of seizures associated with Dravet syndrome is classified here.
Mirogabalin indicated for the treatment of peripheral neuropathic pain is classified in N02BG - Other analgesics and antipyretics, while the other gabapentinoids, gabapentin and pregabalin, are classified here.